Showing results (21-30 of 672) with videos related to
Sort By:
Pageof 68
Handbook of Experimental Pharmacology|December 20, 2014
Emerging small molecule drugsSophie Colin, Giulia Chinetti-Gbaguidi, Jan A Kuivenhoven, et al.Trends in Molecular Medicine|September 12, 2002
The role of PPARs in atherosclerosisCaroline Duval, Giulia Chinetti, Francois Trottein, et al.Cellular and Molecular Life Sciences : CMLS|December 17, 2014
Nuclear bile acid signaling through the farnesoid X receptorClaire Mazuy, Audrey Helleboid, Bart Staels, et al.Nature Reviews. Endocrinology|September 17, 2016
PPARs in obesity-induced T2DM, dyslipidaemia and NAFLDBarbara Gross, Michal Pawlak, Philippe Lefebvre, et al.Gut|June 11, 2024
Nuclear receptors: pathophysiological mechanisms and drug targets in liver diseaseVanessa Dubois, Philippe Lefebvre, Bart Staels, et al.PPAR Research|September 20, 2012
Coordinated Regulation of PPARγ Expression and Activity through Control of Chromatin Structure in Adipogenesis and ObesityJérôme Eeckhoute, Frédérik Oger, Bart Staels, et al.FEBS Letters|April 14, 2011
Control of nuclear receptor activities in metabolism by post-translational modificationsWahiba Berrabah, Pierrette Aumercier, Philippe Lefebvre, et al.The Journal of Clinical Investigation|April 4, 2017
Distinct but complementary contributions of PPAR isotypes to energy homeostasisVanessa Dubois, Jérôme Eeckhoute, Philippe Lefebvre, et al.Biochemical and Biophysical Research Communications|December 15, 2010
Liver X Receptor (LXR) activation negatively regulates visfatin expression in macrophagesThérèse Hèrvée Mayi, Elena Rigamonti, François Pattou, et al.Nucleus (Austin, Tex.)|January 8, 2015
The ubiquitous transcription factor CTCF promotes lineage-specific epigenomic remodeling and establishment of transcriptional networks driving cell differentiationJulie Dubois-Chevalier, Bart Staels, Philippe Lefebvre, et al.Pageof 68